🧪 Anthem Biosciences IPO – Scientific Dhamaka Ya Listing Ka Tadka?
Kya aapne kabhi socha hai ki lab coat pehne waale scientists bhi paisa kamaane ke liye stock market me aate hain? Nahi na? Toh chalo, aaj milte hain ek aise IPO se jo biology se paisa kamaane ka naya tareeka leke aaya hai — ji haan, hum baat kar rahe hain Anthem Biosciences IPO ki
Ye koi normal company nahi, bhai sahab… ye hai India ke top pharmaceutical R&D aur manufacturing giants me se ek, jiska IPO aa raha hai ek dhamakedar entry lene! Ab sawal ye uthta hai – Kya yeh IPO hum retail investors ke liye bhi lab-tested faayde ka formula hai, ya sirf bade investors ka chemical romance?
Aaiye, is IPO ko microscope ke neeche rakh ke dekhte hain. 😉
🔬 Anthem Biosciences Ka DNA – Company Ka Profile
Anthem Biosciences ek Contract Research and Development Manufacturing Organization (CRDMO) hai — bhai iska matlab ye hai ki dusri pharmaceutical companies ke liye yeh log research, development aur manufacturing karte hain.
🧬 Kya banati hai yeh company?
- APIs (Active Pharmaceutical Ingredients) – jo actual dawa ka chemical hota hai.
- Peptides, Probiotics, Enzymes, Biosimilars – sunte hi biology wali feeling aati hai.
- Nutritional & Speciality Ingredients – khaane ke saath dawa bhi.
🏭 Kaha hai iska lab aur factory?
- Karnataka mein do badi facilities hai
- Nayi unit bhi develop ho rahi hai – fermentation ke capacity mein heavy expansion
- 44 countries me 550+ clients! Wah bhai wah, international level ka game hai
Yeh company science ke saath paisa bhi banati hai. 🤓💰
📊 IPO Ka Formula – Numbers Jo Dimag Ghuma De
Chaliye IPO ke numbers dekh lete hain, bina maths teacher ke darr ke
| 💼 Detail | 🔢 Information |
|---|---|
| IPO Opening Date | 14 July 2025 |
| Closing Date | 16 July 2025 |
| Price Band | ₹540 – ₹570 per share |
| Minimum Lot | 26 shares (₹14,820 approx.) |
| Total Issue Size | ₹3,395 crore |
| Issue Type | Pure Offer For Sale (OFS) |
| Listing Exchanges | NSE & BSE |
| Face Value | ₹2 per share |
| Tentative Listing Date | 21 July 2025 |
📌 Important Point:
Ye IPO me company ek paisa bhi khud ke liye nahi utha rahi! Sirf purane shareholders apna hissa bech rahe hain. Matlab company ki growth ke liye koi fresh fund nahi aa raha — bas purane log nikal rahe hain.
Matlab:
Party to ho rahi hai… par bill aap bhar rahe ho 😅
🏛️ Company Ki Financial Health – Paisa Waise Hi Ban Raha Hai?
Ab company lab mein experiments kar rahi hai, lekin kya woh balance sheet mein bhi faayda kar rahi hai? Dekhte hain ek quick X-ray:
💸 Revenue (FY25): ₹1,930 crore
- FY24 me ₹1,483 crore tha – matlab 30% se zyada ka growth
- Company growth mode mein hai, aur woh bhi sustainable tareeke se
💰 Net Profit (PAT): ₹451 crore
- FY24 ka PAT tha ₹367 crore – again, bada jump.
💎 Net Worth: ₹2,410 crore
📉 Debt: ₹109 crore
- Matlab debt/equity ratio bahut hi low hai – safe investment point of view se.
📊 Profit Margin:
- EBIT ~31.5%
- ROE ~21%
- ROCE ~24%
In sab data ko dekhke ek hi baat kehni padegi:
Anthem Biosciences ne na sirf chemistry mein top kiya hai, balki accountancy mein bhi A+ student nikli
🧠 IPO Ka Use – Paisa Kaha Ja Raha Hai?
Yaha thoda shocking twist hai. Is IPO se company khud ek paisa bhi nahi le rahi. Ye poora ka poora IPO OFS hai – matlab:
Promoters aur existing investors apne shares bech rahe hain.
Aapka paisa unke bank account mein jaayega, R&D ya facility expansion mein nahi.
Thoda sad moment… 😓
Lekin agar company pe trust ho, to long-term me profit bhi ho sakta hai.
🌎 Clients & Market – Global Reach With Scientific Touch
Yeh company sirf India me hi nahi, balki USA, EU, Japan jaise developed countries me bhi apni services de rahi hai.
- 550+ clients
- 44 countries
- Majority revenue export se aata hai
Matlab iska “Atmanirbhar” model bhi export pe dependent hai — aur wo bhi science export.
Ye baat investors ke liye double positive hai:
- Dollar me kamaai
- Stable client base
⚠️ Risk Analysis – Har Chemical Safe Nahi Hota
Ab IPO me paisa lagane se pehle hamesha uske side effects dekhne chahiye
❗ High Valuation
- Estimated P/E ratio 71x ke around hai – thoda overvalued lag raha hai.
- P/B ratio bhi 13x ke aas-paas – premium tag.
❗ Revenue Dependency
- Top 5 clients se hi 71% revenue aa raha hai.
- Koi ek client agar chala gaya toh jhatka lag sakta hai.
❗ OFS Only
- Naya paisa business me nahi lag raha – toh investor ka trust pe depend karega.
❗ Competition
- Syngene, Divi’s, Sai Life Sciences jaise players ke sath competition high hai.
❗ Working Capital Stress
- Receivables ~90 days – matlab paisa late milta hai.
In sabko mila ke dekha jaye toh:
IPO me excitement hai, lekin side effects bhi prescription ke bina nahi milne chahiye 😄
🧾 Grey Market Premium (GMP) – Listing Mein Mazaa Aayega?
Latest reports ke according, GMP chal raha hai ₹95–₹100 ke beech.
Agar price ₹570 fix hota hai, aur GMP ₹100 ka hai, toh listing ₹670 tak ho sakti hai.
Matlab listing day pe ek 15–18% ka premium milne ki umeed hai. Baki market sentiment pe depend karega.
📌 Retail Investor Guide – Aap Kya Karein?
Agar aap soch rahe hain ki “Apply karu ya na karu?” toh yeh chart aapke liye:
| Aapka Investor Type | Suggestion |
|---|---|
| Long-term (1–3 years) | ✅ Apply kar sakte hain |
| Listing Gain Wale | 🤞 Apply karo, lekin risk samajh ke |
| Risk Averse | 🚫 Avoid karo – valuation thoda high hai |
| Pharma Sector Believer | ✅ Definitely try kar sakte ho |
| FOMO Wale Bhai | 😅 Thoda research aur patience rakho |
📈 Apply Karein Ya Bypass Karein?
Anthem Biosciences IPO ek high-quality company ka IPO hai, lekin valuation premium hai aur paisa business me nahi ja raha. Company ke fundamentals zabardast hain, lekin listing ke baad market mood agar kharab hua, toh giraawat bhi ho sakti hai.
🧭 Aur IPO ke baare mein aur seekhna hai?
👉 Aap mera pehla blog bhi padho jisme detail mein bataya gaya hai IPO kya hota hai aur kyu game-changer hai
💬 Aapki Baari – Comment Mein Batao!
💥 Aapko Anthem Biosciences IPO kaisa laga?
🔸 Kya aap apply karne wale ho?
🔸 Kitna lot apply karoge?
🔸 Listing ke baad kitna profit expect kar rahe ho?
🔸 IPO allotment mila ya fir waitlist mein reh gaye?
👇 Comments mein likho – sabki investment journey ka pata chal
